Opportunities for immunotherapy in microsatellite instable colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1249, doi. 10.1007/s00262-016-1832-7
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 10
Results: 14
1
2
The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.
- Published in:
- 2016
- By:
- Publication type:
- Report
3
Modulation of innate immunity in the tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1261, doi. 10.1007/s00262-016-1859-9
- By:
- Publication type:
- Article
4
The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1169, doi. 10.1007/s00262-016-1873-y
- By:
- Publication type:
- Article
5
Concepts in glioma immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1269, doi. 10.1007/s00262-016-1874-x
- By:
- Publication type:
- Article
6
Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1177, doi. 10.1007/s00262-016-1877-7
- By:
- Publication type:
- Article
7
Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1149, doi. 10.1007/s00262-016-1878-6
- By:
- Publication type:
- Article
8
Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1159, doi. 10.1007/s00262-016-1879-5
- By:
- Publication type:
- Article
9
4-1BB agonism: adding the accelerator to cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1243, doi. 10.1007/s00262-016-1829-2
- By:
- Publication type:
- Article
10
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1189, doi. 10.1007/s00262-016-1881-y
- By:
- Publication type:
- Article
11
Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1213, doi. 10.1007/s00262-016-1883-9
- By:
- Publication type:
- Article
12
A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1233, doi. 10.1007/s00262-016-1886-6
- By:
- Publication type:
- Article
13
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1223, doi. 10.1007/s00262-016-1887-5
- By:
- Publication type:
- Article
14
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1201, doi. 10.1007/s00262-016-1880-z
- By:
- Publication type:
- Article